1h Free Analyst Time
The bioprocess technology market is poised to grow by $55.84 bn during 2022-2026, accelerating at a CAGR of 12.27% during the forecast period. The report on the bioprocess technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in infectious diseases, an increase in chronic diseases, and growing healthcare expenditure in developing countries.
The bioprocess technology market analysis includes the end-user segment and geographic landscape.
The bioprocess technology market is segmented as below:
By End-user
- Biopharmaceutical companies
- Contract manufacturing organizations
- Academic research institute
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the bioprocess technology market covers the following areas:
- Bioprocess technology market sizing
- Bioprocess technology market forecast
- Bioprocess technology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global bioprocess technology market: Advanced Instruments LLC, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Catalent Inc., Charles River Laboratories International Inc., Corning Inc., Dover Corp., Emerson Electric Co., Fujifilm Diosynth Biotechnologies USA Inc., General Electric Co., Koninklijke Philips NV, Lonza Group Ltd., Merck KGaA, Nova Biomedical Corp., Repligen Corp., Sartorius AG, STADA Arzneimittel AG, Thermo Fisher Scientific Inc., Univercells SA, and Eppendorf AG.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing clinical trials in countries.`
According to the report, one of the major drivers for this market is the increase in infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Instruments LLC
- Becton Dickinson and Co.
- Boehringer Ingelheim International GmbH
- Catalent Inc.
- Charles River Laboratories International Inc.
- Corning Inc.
- Dover Corp.
- Emerson Electric Co.
- Fujifilm Diosynth Biotechnologies USA Inc.
- General Electric Co.
- Koninklijke Philips NV
- Lonza Group Ltd.
- Merck KGaA
- Nova Biomedical Corp.
- Repligen Corp.
- Sartorius AG
- STADA Arzneimittel AG
- Thermo Fisher Scientific Inc.
- Univercells SA
- Eppendorf AG